BIND THERAPEUTICS INC Inactive Instrument
BIND Therapeutics Inc Stock Nasdaq
Equities
US05548N1072
Biotechnology & Medical Research
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Managers | Title | Age | Since |
|---|---|---|---|
Stephen Zale
CTO | Chief Tech/Sci/R&D Officer | 68 | 06-10-31 |
Tom Baker
IRC | Investor Relations Contact | - | - |
Neil Bander
PRN | Corporate Officer/Principal | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | - | 16-07-23 |
| 1st Jan change | Capi. | |
|---|---|---|
| +7.50% | 111B | |
| +11.37% | 106B | |
| -12.35% | 22.24B | |
| +0.44% | 21.25B | |
| -4.18% | 18.97B | |
| -37.85% | 18.52B | |
| -9.08% | 16.81B | |
| +38.35% | 12.54B | |
| -24.40% | 8.09B |
